Home
|
About IAC
|
Contact
|
A-Z Index
|
Donate
|
Shop
|
SUBSCRIBE
Immunization Action Coalition
IAC Home
|
IAC Express
|
2014 Issues
|
Issue 1158
IAC Express: Weekly immunization news and information
Issue 1158: December 16, 2014

Ask the Experts–Question of the Week: My patient is a 14-year-old girl who has received one dose of bivalent HPV vaccine …read more


TOP STORIES
IAC WEB SECTIONS
OFFICIAL RELEASES AND ANNOUNCEMENTS
FEATURED RESOURCES
JOURNAL ARTICLES AND NEWSLETTERS
CONFERENCES AND MEETINGS  
TOP STORIES
FDA approves the use of Gardasil 9 (Merck) 9-valent HPV vaccine in the U.S.

On December 10, FDA announced the approval of Gardasil 9 (Merck), a human papillomavirus (HPV) 9-valent vaccine. The first two paragraphs of the FDA press release are reprinted below.

The U.S. Food and Drug Administration today approved Gardasil 9 (Human Papillomavirus 9-valent Vaccine, Recombinant) for the prevention of certain diseases caused by nine types of Human Papillomavirus (HPV). Covering nine HPV types, five more HPV types than Gardasil (previously approved by the FDA), Gardasil 9 has the potential to prevent approximately 90 percent of cervical, vulvar, vaginal and anal cancers.

Gardasil 9 is a vaccine approved for use in females ages 9 through 26 and males ages 9 through 15. It is approved for the prevention of cervical, vulvar, vaginal and anal cancers caused by HPV types 16, 18, 31, 33, 45, 52 and 58, and for the prevention of genital warts caused by HPV types 6 or 11. Gardasil 9 adds protection against five additional HPV types—31, 33, 45, 52 and 58—which cause approximately 20 percent of cervical cancers and are not covered by previously FDA-approved HPV vaccines.


ACIP has not yet made any recommendations for the use of Gardasil 9.

Related Links Back to top


CDC publishes estimates of illnesses and hospitalizations averted by vaccination during the 2013–14 influenza season

CDC published Estimated Influenza Illnesses and Hospitalizations Averted by Vaccination—United States, 2013–14 Influenza Season in the December 12 issue of MMWR (pages 1151–1154). The first paragraph is reprinted below.

The Advisory Committee on Immunization Practices recommends annual influenza vaccination for all persons aged ≥6 months to reduce morbidity and mortality caused by influenza in the United States. CDC previously developed a model to estimate that annual influenza vaccination resulted in 1.1–6.6 million fewer cases and 7,700–79,000 fewer hospitalizations per season during the 2005–2013 influenza seasons. For the 2013–14 influenza season, using updated estimates of vaccination coverage, vaccine effectiveness, and influenza hospitalizations, CDC estimates that influenza vaccination prevented approximately 7.2 million illnesses, 3.1 million medically attended illnesses, and 90,000 hospitalizations associated with influenza. Similar to prior seasons, fewer than half of persons aged ≥6 months are estimated to have been vaccinated. If influenza vaccination levels had reached the Healthy People 2020 target of 70%, an estimated additional 5.9 million illnesses, 2.3 million medically attended illnesses, and 42,000 hospitalizations associated with influenza might have been averted. For the nation to more fully benefit from influenza vaccines, more effort is needed to reach the Healthy People 2020 target.

Related Links Back to top


IAC’s Dr. L.J Tan interviewed on PBS NewsHour about influenza

On December 11, Litjen (L.J) Tan, MS, PhD, chief strategy officer, Immunization Action Coalition, was interviewed on the national PBS NewsHour in a segment titled What you need to know about this year’s elevated flu threat. The video and transcript of the interview with PBS's Gwen Ifill are available online. The segment includes valuable information for healthcare professionals and their patients.

Related Links Back to top


IAC Spotlight! Subscribe to immunization-related email news services from CDC, AAP, VEC, and more

The Email News Services section on immunize.org includes descriptions and subscription information for more than 25 immunization-related e-newsletters and email updates published by governmental and non-governmental agencies, professional societies, academic centers, and nonprofit organizations.

IAC's listing of email news offerings includes CDC's Email Subscription service, AAP's Immunization Initiative Newsletter, Vaccine Education Center's (VEC) Vaccine Update and Parent PACK Newsletters, EZIZ.org email news updates, and many more. Browse IAC's selection of e-newsletters and email updates for healthcare professionals, and subscribe to one or more of these helpful resources.

If you have additional email news services to recommend for inclusion on immunize.org, please send your suggestion(s) by email to maryq@immunize.org.

Back to top


IAC WEB SECTIONS
"Ask the Experts" web section about pneumococcal vaccines updated

The Pneumococcal Vaccines (PCV13 and PPSV23) web section of Ask the Experts was recently updated.

IAC’s Ask the Experts web section is a compilation of common as well as challenging questions and answers (Q&As) about vaccines and their administration. The experts are Andrew T. Kroger, MD, MPH, medical officer, and Donna L. Weaver, RN, MN, nurse educator. Both are at CDC's National Center for Immunization and Respiratory Diseases. The Q&As have been featured in previous issues of IAC ExpressNeedle Tips, and Vaccinate Adults.

Related Links Subscribe to IAC Express and receive a new "Ask the Experts" Q&A every week, as well as several special editions of "Ask the Experts" throughout the year.

Back to top


OFFICIAL RELEASES AND ANNOUNCEMENTS
CDC requests public comment on proposed new VAERS form; comments must be received by January 23

CDC published a request for public comment in the Federal Register on November 24. The "Summary" section of the notice is published below in its entirety.

The Centers for Disease Control and Prevention (CDC), located within the Department of Health and Human Services (HHS), is publishing this notice requesting public comment on the proposed VAERS 2.0 form, which is intended to replace the current VAERS-1 form (https://vaers.hhs.gov/resources/vaers_form.pdf). CDC and the U.S. Food and Drug Administration (FDA) co-administer the Vaccines Adverse Event Reporting System (VAERS), a post-licensure (i.e., after vaccines have been licensed by the FDA and are being used in the community) reporting system that accepts submitted reports of adverse events that occur after vaccination from healthcare providers, manufacturers, and the public. Healthcare providers and vaccine manufacturers are required to submit VAERS reports. The National Childhood Vaccine Injury Act of 1986, section 2125 of the Public Health Service Act (42 U.S.C. 300aa-25) authorized VAERS. The current VAERS form has been used since 1990.

Access the entire Federal Register notice, which includes information about how to submit a comment.

Back to top


FEATURED RESOURCES
Influenza is serious; many resources are available to aid healthcare professionals in vaccinating

Vaccination remains the single most effective means of preventing influenza, and is recommended for everyone age six months and older. If you don't provide influenza vaccination in your clinic, please recommend vaccination to your patients and refer them to a clinic or pharmacy that provides vaccines or to the HealthMap Vaccine Finder to locate sites near their workplaces or homes that offer influenza vaccination services.

Following is a list of resources related to influenza disease and vaccination for healthcare professionals and the public: Back to top


JOURNAL ARTICLES AND NEWSLETTERS
CDC reports on global surveillance of bacterial vaccine-preventable diseases

CDC published Global Invasive Bacterial Vaccine-Preventable Diseases Surveillance—2008–2014 in the December 12 issue of MMWR (pages 1159–1162). A summary made available to the press is reprinted below.

Meningitis and pneumonia are leading causes of morbidity and mortality in children globally. Since 2007, the World Health Organization (WHO) has recommended using pneumococcal conjugate vaccine (PCV) in childhood immunization programs. The WHO Invasive Bacterial and Vaccine Preventable Disease (IB-VPD) surveillance network includes sentinel hospitals and laboratories that report clinical and laboratory data on cases of suspected meningitis, pneumonia or sepsis among children <5 years old to the national ministries of health and WHO. IB-VPD syndromic surveillance with case-based data and laboratory case confirmation provides important data to guide decisions to introduce PCV. As more countries introduce PCV, it is important for this network to continue to improve to be able to assess the impact of this vaccine globally and act as a platform for surveillance of other diseases.

Back to top


CDC publishes two new Ebola reports as MMWR Early Releases

On December 12, CDC published the following two articles about Ebola as MMWR Early Releases. Related Link Back to top


CDC reprints four articles about Ebola that were previously published as MMWR Early Releases

CDC published the following four articles about Ebola in the December 12 issue of MMWR. The first three articles were previously published as MMWR Early Releases on December 9; the last article was published as an MMWR Early Release on December 5 and covered in IAC Express on December 9.
  1. Airport Exit and Entry Screening for Ebola—August–November 10, 2014
  2. Ebola Virus Disease in Health Care Workers—Sierra Leone, 2014
  3. Rapid Assessment of Ebola Infection Prevention and Control Needs—Six Districts, Sierra Leone, October 2014
  4. Clinical Inquiries Regarding Ebola Virus Disease Received by CDC—United States, July 9–November 15, 2014
Back to top


CONFERENCES AND MEETINGS
Abstract submission deadline for 2015 NACCHO conference is December 21

The 2015 annual National Association of County & City Health Officials (NACCHO) conference, Envisioning the Future: Creating Our Path, will be held in Kansas City, MO, on July 7–9, 2015. The deadline to submit abstracts for this conference is December 21, 11:59 p.m. (PT). Back to top


Save the date for the 2015 California Immunization Coalition Summit to be held April 26–27

The 2015 California Immunization Coalition Summit will be held April 26–27, 2015 in Riverside, CA. The Summit will focus on communicating the power of vaccines and readiness to deal with and communicate about new vaccine issues as they arise. The deadline for abstract submissions is January 23. Back to top


ASK THE EXPERTS
Question of the Week

My patient is a 14-year-old girl who has received one dose of bivalent HPV vaccine (HPV2, Cervarix, GlaxoSmithKline) and now wants to change over to quadrivalent HPV vaccine (HPV4, Gardasil, Merck). What is the recommendation to be followed? 

Answer: You can complete the series with HPV4 (two more doses), which will assure protection against HPV types 16 and 18 (those types most likely to cause cervical and other cancers and that are in both HPV2 and HPV4). However, receiving only two doses of HPV4 may provide less protection against genital warts than the usual 3 doses. More information is available at www.cdc.gov/mmwr/pdf/rr/rr6305.pdf.

About IAC's Question of the Week

Each week, IAC Express highlights a new, topical, or important-to-reiterate Q&A. This feature is a cooperative venture between IAC and CDC. William L. Atkinson, MD, MPH, IAC's associate director for immunization education, chooses a new Q&A to feature every week from a set of Q&As prepared by experts at CDC’s National Center for Immunization and Respiratory Diseases.

We hope you enjoy this new feature and find it helpful when dealing with difficult real-life scenarios in your vaccination practice. Please encourage your healthcare professional colleagues to sign up to receive IAC Express at www.immunize.org/subscribe.

If you have a question for the CDC immunization experts, you can email them directly at nipinfo@cdc.gov. There is no charge for this service.

Related Links Back to top
 

About IAC Express
The Immunization Action Coalition welcomes redistribution of this issue of IAC Express or selected articles. When you do so, please add a note that the Immunization Action Coalition is the source of the material and provide a link to this issue.
If you have trouble receiving or displaying IAC Express messages, visit our online help section.
IAC Express is supported in part by Grant No. U38IP000589 from the National Center for Immunization and Respiratory Diseases, CDC. Its contents are solely the responsibility of IAC and do not necessarily represent the official views of CDC. IAC Express is also supported by educational grants from the following companies: bioCSL Inc.; AstraZeneca; Merck Sharp & Dohme Corp.; Novartis Vaccines; Ortho Clinical Diagnostics, Inc.; Pfizer, Inc.; and sanofi pasteur.
IAC Express Disclaimer
ISSN: 1526-1786

Our mailing address is
Immunization Action Coalition
2550 University Avenue West, Suite 415 North
Saint Paul, MN 55114

Copyright (C) 2014 Immunization Action Coalition
All rights reserved.

Subscribe Today: IAC Express, Needle Tips, and Vaccinate Adults: the up-to-date immunization information you need
IAC Express
IAC Express Home
2015 Issues
2014 - 1997 Issues
immunize.org homepage
Shop IAC
Make a Donation
Follow Us
Follow IAC on Facebook
Follow IAC on Twitter
Follow IAC on YouTube
Combined Federal Campaign
Combined Federal Campaign
Federal employees, including military, may contribute to IAC by using code #10612 on their pledge cards.
Video of the Week
Teen Boys Create HPV Vaccine Videos
Teen Boys Create HPV Vaccine Videos: The New Jersey Department of Health runs an annual contest for youth to create videos about adolescent immunizations. This past year, several HPV vaccine videos were created by teen boys hoping to bring attention to the importance of including boys in HPV vaccination efforts.
Visit the VOTW archive
IAC's Free Publications
Subscribe to IAC's Free Publications!
Up-to-date immunization information, practice oriented, and CDC reviewed. Sign up today!
Laminated Schedules
Purchase IAC's laminated schedules for your exam room today!
Laminated child & teen and adult CDC Immunization Schedules are ready for heavy duty use
Patient Record Cards
Purchase IAC's patient record cards today!
Record cards for patients -- child & teen, adult, and lifetime -- are printed on durable paper and sized to fit in a wallet when folded
DVD Immunization Techniques
Purchase Immunization Techniques DVD
Every practice should have this award winning, "how-to" training video
The Vaccine Handbook (Purple Book)
Order a copy of this practical guide today!
Order your copy today!
Calendar of Events
Conferences, meetings, and training opportunities
Conferences, meetings, and training opportunities
Technically Speaking
Read Dr. Wexler's monthly column for practical advice on vaccination topics
Read Dr. Wexler's column for the Vaccine Education Center's monthly newsletter, Vaccine Update
Editorial Information
Executive Editor: Deborah L. Wexler, MD
Editor: Mary Quirk
Associate Editor: Teresa Anderson, DDS, MPH
Consulting Editor: Marian Deegan, JD
Production Editor: Janelle T. Anderson, MA
Issue Abbreviations
AAFP: American Academy of Family Physicians
AAP: American Academy of Pediatrics
ACIP: Advisory Committee on Immunization Practices
CDC: Centers for Disease Control and Prevention
FDA: Food and Drug Administration
IAC: Immunization Action Coalition
MMWR: Morbidity and Mortality Weekly Report
NCIRD: National Center for Immunization and Respiratory Diseases
VIS: Vaccine Information Statement
WHO: World Health Organization
 
 
- Guide to immunize.org -
A-Z INDEX
ABOUT IAC
ACIP RECOMMENDATIONS
ADDITIONAL RESOURCES
ADULT VACCINATION
ADULT VACCINATION GUIDE
ASK THE EXPERTS
Combination Vaccines
Diphtheria
Hepatitis A
Hepatitis B
Question of the Week
Vaccine Storage and Handling
What's New
>> view all
BILLING & CODING
BIRTH DOSE GUIDEBOOK
CALENDAR
CDC INFORMATION
CDC SCHEDULES
CLINIC RESOURCES
Administering Vaccines
Documenting Vaccination
Scheduling Vaccination
Screening for Contraindications
Storage & Handling
Vaccine Recommendations
>> view all
COALITIONS
CONTINUING EDUCATION
CONTRIBUTE TO IAC
DEAR COLLEAGUE LETTER
HPV VACCINE
DEAR COLLEAGUE LETTER
MCV4 DOSE #2
DISEASES & VACCINES
Diphtheria
Hepatitis A
Hepatitis B
Influenza
Varicella
>> view all
DONATE TO IAC
EMAIL NEWS SERVICES
EDUCATIONAL MATERIALS
FAQs
FAVORITES (WEB SECTIONS)
FDA PRODUCT APPROVALS
GIVE BIRTH TO THE END OF
HEP B
HANDOUTS FOR PATIENTS &
STAFF
Administering Vaccines
Adult Vaccination
Documenting Vaccinations
Managing Vaccine Reactions
Parent Handouts
Patient Schedules
Questions & Answers
Recommendations
Screening Checklists
Standing Orders
Storage & Handling
Supplies Checklist
Talking with Parents
Temperature Logs
Top Handouts
Translations
Vaccine Index
>> view all
HEPATITIS B BIRTH DOSE
HONOR ROLLS
HepB Birth Dose
Influenza Vaccination for HCP
IAC EXPRESS
IMAGES
IMMUNIZATION TECHNIQUES
DVD
LAMINATED SCHEDULES
MANUFACTURERS
NATIONAL ADULT & INFLUENZA IMMUNIZATION SUMMIT
NEEDLE TIPS
NEWS & INFORMATION
OFFICIAL RELEASES
ACIP
CDC
FDA
>> view all
PACKAGE INSERTS
PARTNERS
PHARMACISTS
PHOTOS
POCKET GUIDES
POWERPOINT SLIDE SETS
PRESS ROOM
PROTECT NEWBORNS
FROM HEP B
PUBLICATIONS
IAC Express
Needle Tips
Vaccinate Adults
THE PURPLE BOOK
QUESTION OF THE WEEK
REGISTRIES
RESOURCE DIRECTORY
SHOP IAC
Immunization Techniques DVD
Laminated Schedules
Patient Record Cards
The Vaccine Handbook:
  A Practical Guide for Clinicians
>> view all
SITE MAP
SLIDE SETS
STANDING ORDERS TEMPLATES
STATE INFORMATION
State Websites
State Laws
State Immunization Managers
>> view all
SUBSCRIBE
SUPPORT IAC
TECHNICALLY SPEAKING
TRANSLATE FOR IAC
TRAVEL (INTERNATIONAL)
UNPROTECTED PEOPLE REPORTS
Chickenpox
Diphtheria
Hepatitis A
Hepatitis B
>> view all
VACCINATE ADULTS
VACCINE CONCERNS
Adjuvants & Ingredients
Alternative Medicine
Autism
Importance of Vaccination
>> view all
THE VACCINE HANDBOOK: A PRACTICAL GUIDE FOR CLINICIANS
VACCINE INFORMATION STATEMENTS
Translations
Vaccine Index
>> view all
VACCINE MANUFACTURERS
VACCINE POLICY & LICENSURE
ACIP
FDA
WHO
>> view all
VACCINE SAFETY
VACCINES & DISEASES
VIDEOS (VIDEO OF THE WEEK)
WHAT'S NEW OR UPDATED AT IAC
Handouts
VISs
Web Sections
>> view all
 
Immunization Action Coalition  •  2550 University Avenue West  •  Suite 415 North  •  Saint Paul, Minnesota  •  55114
tel 651-647-9009  •  fax 651-647-9131
 
 
 
This website is supported in part by a cooperative agreement from the National Center for Immunization and Respiratory Diseases (Grant No. 6NH23IP22550) at the Centers for Disease Control and Prevention (CDC) in Atlanta, GA. The website content is the sole responsibility of IAC and does not necessarily represent the official views of CDC.